Comparative efficacy and safety of etanercept biosimilars in comparison with etanercept in patients with rheumatoid arthritis who have insufficient response to methotrexate: A network meta-analysis

Comparative efficacy and safety of adalimumab biosimilars and adalimumab in patients with rheumatoid arthritis presenting an insufficient response to methotrexate: a network meta-analysis

Zeitschrift für Rheumatologie ◽

10.1007/s00393-021-01013-3 ◽

2021 ◽

Author(s):

Young Ho Lee ◽

Gwan Gyu Song

Keyword(s):

Rheumatoid Arthritis ◽

Meta Analysis ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Insufficient Response

Download Full-text

Comparative efficacy and safety of infliximab and its biosimilars in patients with rheumatoid arthritis presenting an insufficient response to methotrexate

Zeitschrift für Rheumatologie ◽

10.1007/s00393-021-01040-0 ◽

2021 ◽

Author(s):

Young Ho Lee ◽

Gwan Gyu Song

Keyword(s):

Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Insufficient Response

Download Full-text

Comparative efficacy and safety of biosimilar adalimumab and originator adalimumab in combination with methotrexate in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials

Clinical Rheumatology ◽

10.1007/s10067-018-4002-9 ◽

2018 ◽

Vol 37 (5) ◽

pp. 1199-1205

Author(s):

Sang-Cheol Bae ◽

Young Ho Lee

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

THU0213 Comparative efficacy and safety of baricitinib 2 MG and 4 MG in patients with active rheumatoid arthritis: a bayesian network meta-analysis of randomized controlled trials

10.1136/annrheumdis-2017-eular.1245 ◽

2017 ◽

Author(s):

YH Lee ◽

YH Seo ◽

GG Song

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

Comparative Efficacy and Safety of Biosimilar Rituximab and Originator Rituximab in Rheumatoid Arthritis and Non-Hodgkin’s Lymphoma: A Systematic Review and Meta-analysis

BioDrugs ◽

10.1007/s40259-019-00376-z ◽

2019 ◽

Vol 33 (5) ◽

pp. 469-483 ◽

Cited By ~ 5

Author(s):

Soohyun Lee ◽

Heeyoung Lee ◽

EunYoung Kim

Keyword(s):

Rheumatoid Arthritis ◽

Systematic Review ◽

Hodgkin’S Lymphoma ◽

Meta Analysis ◽

Hodgkin's Lymphoma ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma

Download Full-text

Comparative efficacy and safety of biosimilar rituximab and originator rituximab in combination with methotrexate in patients with active rheumatoid arthritis: A Bayesian network meta-analysis

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp203360 ◽

2019 ◽

Vol 57 (04) ◽

pp. 188-196 ◽

Cited By ~ 4

Author(s):

Sang-Cheol Bae ◽

Young Ho Lee

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Efficacy And Safety ◽

Comparative Efficacy

Download Full-text

Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

Clinical Drug Investigation ◽

10.1007/s40261-019-00863-9 ◽

2019 ◽

Vol 40 (1) ◽

pp. 65-72 ◽

Cited By ~ 1

Author(s):

Young Ho Lee ◽

Gwan Gyu Song

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text

Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled tri

International Journal of Rheumatic Diseases ◽

10.1111/1756-185x.12822 ◽

2015 ◽

Vol 19 (11) ◽

pp. 1103-1111 ◽

Cited By ~ 15

Author(s):

Young Ho Lee ◽

Sang-Cheol Bae

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Tumor Necrosis Factor Inhibitors ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled ◽

Necrosis Factor

Download Full-text

Comparative efficacy and safety of tumor necrosis factor inhibitors and their biosimilars in patients with rheumatoid arthritis having an insufficient response to methotrexate

Zeitschrift für Rheumatologie ◽

10.1007/s00393-021-01041-z ◽

2021 ◽

Author(s):

Young Ho Lee ◽

Gwan Gyu Song

Keyword(s):

Rheumatoid Arthritis ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Inhibitors ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Insufficient Response ◽

Necrosis Factor

Download Full-text

Comparative efficacy and safety of 100 mg and 200 mg filgotinib administered to patients with active rheumatoid arthritis: A Bayesian network meta-analysis of randomized controlled trials

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp203635 ◽

2020 ◽

Vol 58 (06) ◽

pp. 293-298

Author(s):

Gwan Gyu Song ◽

Young Ho Lee

Keyword(s):

Rheumatoid Arthritis ◽

Bayesian Network ◽

Randomized Controlled Trials ◽

Active Rheumatoid Arthritis ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Randomized Controlled

Download Full-text